Astute Medical
Combined with a test for procalcitonin, the test may allow doctors to alter treatment of severe sepsis in time to save a patient's kidney.
BioMérieux Acquires Biomarker Discovery Firm Astute Medical for $90M
Astute is the maker of Nephrocheck, an immunoassay test for biomarkers predicting acute kidney injury.
Heroin Detection Assay, Kidney Injury System Cleared by FDA in November
Microgenics, Astute Medical, and Siemens were among the firms whose tests and/or systems were cleared by the FDA for marketing last month.
Ortho Clinical AKI Test Receives CE Mark
The test, developed under license from Astute Medical, can now be used on Ortho Clinical's Vitros 3600/5600 Immunodiagnostic Systems.
Astute Medical Expands Agreements with BioMérieux, Ortho To Expand Kidney Test Access
The NephroCheck test combined with a recommended-care procedure reduced the occurrence of moderate-to-severe AKI following cardiac surgery by 33.9 percent, Astute said.